Case Study Analysis

This presentation provides a comprehensive analysis of a case study, covering various aspects such as the internal structure, market research techniques, research and development methodology, external perspective, marketing perspective, and technology perspective. It explores the challenges, innovations, and strategies implemented in the case study.

CASE STUDY ANALYSIS
NAME OF THE STUDENT
NAME OF THE UNIVERSITY
AUTHOR'S NOTE

Internal Structure
• The internal hierarchy network within the organization.
• The strategy and effort implemented for introducing
innovations.
• Weak HR policy
• Importance of board of directors.

• Importance of the senior management team internally.
- The role of director and alignment of authority.
- Internal controls over financial reporting
- Resource allocation

Market Research Techniques
• Market research techniques undertaken
• Kinds of market research
• Importance of market research
• Source of data in market research

- Primary sources of data
- Statistical surveying
- Varying methods and the need for new implementation.
- Limited understand of their doctors and physician needs.

Research and Development Methodology
 New advancement technology
 Introduction of innovation.
 Challenges in the innovation phase.
 Medicinal gadgets

 Innovation of therapeutic gadgets.
 Application of patient after development.
 Requirement for expansive scale ventures.
 Gadgets require substantial capital cost.

External Perspective
 Getting right kind of product development.
 Virtual companies.
 Open innovation technology.
 The perspective of the future.

- The expansion of outer assets
- Basic achievement factor
- The issues

Marketing Perspective
 Visiting programmed for customer
 Emphatically designs
 Lead user process

- Importance of stake holders.
- Lack of vision
- Importance of CVP
- Improve the focus

Technology Perspective
 The challenges
 The patent rights
 Advancement in technology

- FDA regulatory body.
- New medications.
- Access to convenient data.

REFERENCE
BAELL, J. AND WALTERS, M.A., 2014. CHEMISTRY: CHEMICAL CON ARTISTS FOIL DRUG DISCOVERY. NATURE NEWS, 513(7519), P.481.
CAMP, D., NEWMAN, S., B PHAM, N. AND J QUINN, R., 2014. NATURE BANK AND THE QUEENSLAND COMPOUND LIBRARY: UNIQUE INTERNATIONAL
RESOURCES AT THE ESKITIS INSTITUTE FOR DRUG DISCOVERY. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 17(3), PP.201-209.
COLMAN, P.M., 2014. CRYSTALLOGRAPHY AND NEW MEDICINES: EXAMPLES FROM INFLUENZA AND CELL DEATH. AUSTRALIAN JOURNAL OF
CHEMISTRY, 67(12), PP.1720-1723.
HUNT, P., SEGALL, M., O'BOYLE, N. AND SAYLE, R., 2017. PRACTICAL APPLICATIONS OF MATCHED SERIES ANALYSIS: SAR TRANSFER, BINDING MODE
SUGGESTION AND DATA POINT VALIDATION. FUTURE MEDICINAL CHEMISTRY, 9(2), PP.153-168.
MCLEAN, L., MICALOS, P.S., MCCLEAN, R. AND PAK, S.C., 2016. EVIDENCE BASED PRACTICE WITHIN THE COMPLEMENTARY MEDICINE
CONTEXT. TANG, 6(3), PP.1-4.
NI, J., WAN, J., KONG, X., CAI, Y., YANG, F., WANG, Y. AND HU, Y., 2016. PHARMACEUTICAL TECHNOLOGY LICENSING: AN ANALYSIS IN THE FIELD OF
CARDIOVASCULAR DISEASE. JOURNAL OF PHARMACEUTICAL INNOVATION, 11(1), PP.34-45.
STOCK, J.K., JONES, N.P., HAMMONDS, T., ROFFEY, J. AND DILLON, C., 2015. ADDRESSING THE RIGHT TARGETS IN ONCOLOGY: CHALLENGES AND
ALTERNATIVE APPROACHES. JOURNAL OF BIOMOLECULAR SCREENING, 20(3), PP.305-317.
STOREY, C.E., 2014. A BRIEF HISTORY OF THE SPECIALTIES FROM FEDERATION TO THE PRESENT. THE MEDICAL JOURNAL OF AUSTRALIA, 201(1), PP.26-28.
UESAWA, Y., SAKAGAMI, H., ISHIHARA, M., KAGAYA, H., KANAMOTO, T., TERAKUBO, S., NAKASHIMA, H., YAHAGI, H., TAKAO, K. AND SUGITA, Y., 2015.
QUANTITATIVE STRUCTURE–CYTOTOXICITY RELATIONSHIP OF 3-STYRYL-2H-CHROMENES. ANTICANCER RESEARCH, 35(10), PP.5299-5307.
UNG, C.O.L., HARNETT, J. AND HU, H., 2018. DEVELOPMENT OF A STRATEGIC MODEL FOR INTEGRATING COMPLEMENTARY MEDICINES INTO
PROFESSIONAL PHARMACY PRACTICE. RESEARCH IN SOCIAL AND ADMINISTRATIVE PHARMACY, 14(7), PP.663-672.